ASCO 2019 | Further progression for CAR T-cell therapy?
Paolo Strati
• 3 Jun 2019
Paolo Strati, MD, of the University of Texas MD Anderson Cancer enter, Houston, RX, discusses the need for larger data sets and further goals to improve CAR T-cell therapy. Dr Strati also discusses the need for further biological understanding and potential studies to explain the unexpected relationship between platelet counts & NK cells observed here. This interview was recorded at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
